Welcome

Darr House was established by Alistair Miller to specialise primarily in the innovation and design of bespoke fluorinated intermediates. In addition, we offer a range of custom synthesis and contractual research opportunities to the agrochemical and pharmaceutical industries, biotech and catalogue companies.

We are developing a range of novel fluorinated intermediates as well as intermediates based on other chemical classes to expand our business portfolio.

The range of chemistry undertaken in our well equipped laboratory covers all aspects of aromatic and heterocyclic chemistry as well some expertise in peptide chemistry and specialisation in organofluorine chemistry.

Our facilities are located within easy reach of Exeter and have good road and rail access to rest of the country and the southwest.
Why Darr House

Darr House is the name of a fictitious country estate in the novel, "Trouble with Lichen" by the famous science fiction author, John Wyndham. The narrative tells of a young and enthusiastic, Diana Brackley who wins a place at the University of Cambridge to study Biochemistry. Whilst there she attends a lecture given by a one time Gilkes Professor of Biochemistry at Cambridge, Francis Saxover.

The lecturer proves inspirational to her and on going down from Cambridge with highest honours she joins the wealthy Saxover (who comes from a successful engineering family in the West Midlands) at his prestigious research institute on the Darr House estate. Whilst there she stumbles on a discovery (previously made by Saxover, who, because of its potential implications does not divulge the information to Diana) of a compound contained in a rare Manchurian lichen, which is able to retard the ageing process by a factor of five. The compound was called Antigerone and its properties had huge implications for the population of Britain at that time.

After I read this book I was so inspired by it that if I was to have my own company one day I would name it after Saxover's research institute, "Darr House" and the "Molecular Innovation" is what we are about.